Haemophilia : the official journal of the World Federation of Hemophilia
In Silico Assessment of Limited Blood Sampling Strategies for Individualised Pharmacokinetic-guided Dosing of Efanesoctocog Alfa in Haemophilia A Patients.
Jelien den Hollander, Marjon H Cnossen, Ron A A Mathôt
Published: 202510.1111/hae.70169
Abstract
INTRODUCTION: Efanesoctocog alfa is a novel factor VIII (FVIII) concentrate with a unique molecular design that enables Von Willebrand Factor-independent clearance in patients with haemophilia A. Limited sampling strategies (LSSs) are necessary to im…
Preview only. Read the full abstract at the source